The FDA granted de novo approval to Neuromod Devices' Lenire, a bimodal neuromodulation device that is the first of its kind to be approved to treat tinnitus, the company announced. The device ...

DUBLIN, June 30, 2022 /PRNewswire/ -- Neuromod Devices Limited, the Irish medical device company specialising in the treatment of tinnitus, has published the results of the company's TENT-A2 ...

Lenire® is a bimodal neuromodulation device which has been proven to provide long term relief from tinnitus that lasts for at least 12-months after treatment in large scale clinical trials. [1], [3] ...

DUBLIN--(BUSINESS WIRE)--Neuromod Devices Limited (“Neuromod”), the Irish medical device company specialising in the treatment of tinnitus, a chronic condition that affects 10-15% of the global ...

Lenire, the first and only tinnitus treatment device of its kind approved by the FDA, is now an option for 2.9 million veterans living with tinnitus through Veterans Affairs. 5 Lenire is the first and ...

DUBLIN, June 30, 2022 /CNW/ -- Neuromod Devices Limited, the Irish medical device company specialising in the treatment of tinnitus, has published the results of the company's TENT-A2 (Treatment ...

is a comprehensive textbook that describes tinnitus, how it is caused, and state-of-the art interventions such as Lenire. Top-ranked tinnitus expert authors of the Textbook of Tinnitus state that ...

Clinical trial concludes that bimodal neuromodulation combining sound and electrical stimulation of the tongue can significantly reduce tinnitus symptoms, and therapeutic effects can be sustained for ...